Synergistic Plant Extract Formulation for Respiratory Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for common cold and flu lack effective prevention and specific remedies, with existing medications often causing adverse reactions and antibiotic use leading to relapses, especially in children and high-risk subjects.
Innovation Solution
A combination of Curcuma longa, Punica granatum, and Zingiber officinale extracts, formulated as buccal or inhalatory compositions, exhibiting strong synergistic antimicrobial, anti-inflammatory, and antiviral activities to treat and prevent disorders of the mouth, throat, and respiratory tract.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If antibiotics are used to treat bacterial infections, then infection symptoms are reduced, but relapses occur frequently especially in children
Solution Approach 1:
The patent converts the harmful effect of antibiotic resistance and relapses into a benefit by using plant extracts with antimicrobial properties that do not cause the same resistance issues. The combination of Curcuma longa, Punica granatum, and Zingiber officinale extracts provides sustained antimicrobial activity without the relapse problem associated with antibiotics.
Solution Approach 2:
The patent uses a composite formulation combining three different plant extracts (Curcuma longa, Punica granatum, and Zingiber officinale) to achieve synergistic antimicrobial effects. This composite approach provides broader spectrum activity and prevents relapses better than single-agent treatments.
2Object-affected harmful factors
If conventional medications are used to treat cold and flu symptoms, then specific symptoms are alleviated, but adverse reactions occur
Solution Approach 1:
The patent uses natural plant extracts that are biodegradable and metabolized without accumulating toxic effects, unlike synthetic medications. The extracts provide symptomatic relief while being safely eliminated by the body, avoiding the adverse reaction profile of conventional drugs.
Solution Approach 2:
The patent changes the chemical parameters of the treatment by using natural plant compounds instead of synthetic drugs. This parameter change from synthetic to natural compounds maintains therapeutic efficacy while eliminating the adverse reactions associated with conventional medications.
3Object-affected harmful factors
If plant extracts are used individually, then some antimicrobial activity is achieved, but the activity is lesser and less consistent
Solution Approach 1:
The patent merges three different plant extracts (Curcuma longa, Punica granatum, and Zingiber officinale) into a single formulation to achieve synergistic effects. The combination provides more consistent and reliable antimicrobial activity than any single extract alone, addressing the reliability issue.
Solution Approach 2:
The patent creates a multi-functional formulation where each plant extract contributes different antimicrobial mechanisms and spectra of activity. This universal approach ensures consistent effectiveness against various pathogens, making the treatment more reliable than individual extracts.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination effectively prevents bacterial plaque formation, fever, and symptoms associated with colds and flu, enhancing salivary lysozyme levels and providing prolonged protection against infections, reducing the need for antibiotics and improving symptom management.
Implementation Method 1
A combination of Curcuma longa, Punica granatum, and Zingiber officinale extracts, formulated as buccal or inhalatory compositions, exhibiting strong synergistic antimicrobial, anti-inflammatory, and antiviral activities
Implementation Method 2
The combination effectively prevents bacterial plaque formation, fever, and symptoms associated with colds and flu, enhancing salivary lysozyme levels and providing prolonged protection against infections
Implementation Method 3
A combination of Curcuma longa, Punica granatum, and Zingiber officinale extracts, formulated as buccal or inhalatory compositions, exhibiting strong synergistic antimicrobial, anti-inflammatory, and antiviral activities
Implementation Method 4
A combination of Curcuma longa, Punica granatum, and Zingiber officinale extracts, formulated as buccal or inhalatory compositions, exhibiting strong synergistic antimicrobial, anti-inflammatory, and antiviral activities
Data Source
AI summary
The present invention relates to formulations containing a combination of extracts from Curcuma longa, Punica granatum and Zingiber officinale, acting synergistically in the treatment and prevention of disorders of the mouth, throat and respiratory tract; the formulation is especially active on disorders of bacterial origin, e.g. those occurring in patients affected by common cold and flu and their complications. The present formulations are particularly useful in the reduction of incidence of sores throat and their infections and in the elimination of antibiotic use, especially among infants and the elderly.